AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Cellular Mechanisms Involved in Muscle Pathology

Recruitingn/aAges 18 Years - anyAllBispebjerg Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The overall purpose of this proposed study is the understanding of cellular mechanisms involved in the pathologic fatty degeneration of muscle. Fatty infiltration in skeletal muscle is observed following sports injuries such as muscle strain injuries and Achilles tendon rupture. It is also observed in the degenerative state after rotator cuff tears as well as in the aging process. While fatty degeneration of skeletal muscle occurs in many different conditions and is known to decrease muscle function, the cellular processes involved in fatty infiltration have not been investigated in human muscle. Hypotheses: 1. There is a high amount of fibro-adipogenic progenitors (FAPs) with an adipogenic pattern in pathologic skeletal muscle following a muscle strain injury and a full Achilles tendon rupture. We hypothesize that there is an increased number of FAPs with an adipogenic signature alrea

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * 18 years and older, male and female, with an acute muscle strain injury (\<14 days post injury) in the calf or hamstring muscles (group 1). Pathological changes visible on an ultrasound scan as hypoechoic areas. * 18 years and older, male and female, with a chronic muscle strain injury (\> 6 months prior to inclusion) in the calf or hamstring muscles (group 2), sequela including recurrent strain injuries, pain and/ or decrease in muscle function. Pathological changes visible on an ultrasound scan as hypo-/ hyperechoic areas. * 18 years and older, male and female, with a full Achilles tendon rupture (\> 1 year prior to inclusion) with pathological changes: Fatty degeneration visible on an ultrasound scan (group 3). Exclusion Criteria: * Type I and II Diabetes, Connective tissue and/or rheumatic diseases, or any observed organ dysfunctions * Daily smoking * Persons with daily intake of non-steroidal anti-inflammatory drugs (NSAIDs) within three months prior to time of contact * Allergic reactions to local anesthesia * Use of anticoagulant treatment * Needle phobia * Any drug or alcohol abuse now or in the past * The absence of any pathological changes visible on an ultrasound scan as hypo-/ hyperechoic areas (group 1 and 2) * The absence of any pathological changes (fatty degeneration) in either the gastrocnemius or the soleus muscle visible on an ultrasound scan (Subject group 3)
๐Ÿ’Š

What it tests

  • Biopsies
๐Ÿ“

Where

1 site
Institute of Sports Medicine Copenhagen, Bispebjerg Hospital, Nielsine Nielsen Vej 11, Building 8
Copenhagen, Denmark
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy